Detected ·
Rivermark Medical, Inc.
——
Rivermark Medical, Inc. raised $20M Series D from Andera Partners, Clarevia Ventures, and other existing investors to advance FloStent, a simpler, reversible treatment option for men with BPH.
- Website
- www.rivermarkmedical.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-04 16:10:40 UTC
- Signal ID
- 8b840818-2073-443e-adf0-0a9255fd1ad4
As the API returns it
{
"id": "8b840818-2073-443e-adf0-0a9255fd1ad4",
"created_at": "2026-06-04T16:10:40.948491Z",
"company_name": "Rivermark Medical, Inc.",
"company_website_url": "www.rivermarkmedical.com",
"company_linkedin_url": "https://www.linkedin.com/company/rivermark-medical-inc",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Rivermark Medical, Inc. raised $20M Series D from Andera Partners, Clarevia Ventures, and other existing investors to advance FloStent, a simpler, reversible treatment option for men with BPH.*"
}